EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study

Kamran Khan

Medical Research Journal · 15.01.2026 · 11

DOI: 10.5603/mrj.112316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Journal, online erschienen am 15.01.2026. Verfasst von Kamran Khan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Khan, K. (2026). Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study. Medical Research Journal, 11(0). https://doi.org/10.5603/mrj.112316

Vancouver

Khan K. Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study. Medical Research Journal. 2026;11(0). doi:10.5603/mrj.112316

BibTeX
@article{Khan2026,
  author = {Khan, Kamran},
  title = {Efficacy and safety of once-weekly oral trelagliptin switched from once-daily dipeptidyl peptidase-4 inhibitor therapy in elderly patients: a single-center observational study},
  journal = {Medical Research Journal},
  year = {2026},
  volume = {11},
  number = {0},
  doi = {10.5603/mrj.112316}
}
Kostenlos starten →